Anatomical-Clinical Base of Adenocarcinoma Pancreatic
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-120
SponsorUniversity Hospital, Toulouse
About this trial
BACAP-2 is a prospective biobank dedicated to the pancreatic adenocarcinoma including clinical data and biological samples from tumor. The aim is to enrich the previous propective collection BACAP in order to support future research projects.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient with pancreatic mass syndrome explored by ultrasound endoscopy with cytopuncture or
Patient with pancreatic mass syndrome explored by an abdominal scanner with and without injection of product contrast and/or puncture of the mass or secondary lesions by radiological route or
Patient with pancreatic adenocarcinoma proven histologically and/or cytologically
Disqualifiers
Patient with a pancreatic tumor whose analysis histological is not an adenocarcinoma
Pregnant or breastfeeding patient
Trial population
Patients with a pancreatic adenocarcinoma proven cytologically or histologically without any treatment
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
collection of biological samples
Other interventionCollection of biological samples including whole blood and micro-biopsy from tissue of pancreas
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Enrichment of prospective BACAP collection
This collection is coming to enrich the prospective BACAP collection of fresh tumor tissue and/or fixed from the micro-biopsy under endoscopic ultrasound
Time frame
5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov